Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Evaluation of immunological persistence following 3-dose priming with GSK Biologicals’ 10-valent pneumococcal conjugate vaccine in study NCT00808444 and safety and immunogenicity following a booster dose of the same vaccine
Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed)
113266
NCT01119625
Infections, Streptococcal
Phase 3
 
This is a follow-up of primary study 111654.
June 2015

Powered by ideaPoint, Inc.